A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The primary purpose of this study is to determine the maximum tolerable dose (MTD) and/or the maximum feasible dose (MFD), as well as to evaluate the safety of JX-594 (Pexa-Vec) injected within hepatic carcinoma tumors.
Epistemonikos ID: 3bdfa3443e55632d97ad8b55a180fc39e95d0dd5
First added on: Mar 23, 2020